Mitochondrial alterations and neuropsychiatric disorders

Current Medicinal Chemistry

Volumn 18, Issue 30, 2011, Pages 4715-4721

  Marazziti, D ^a   Baroni, S ^a   Picchetti, M ^a   Landi, P ^a   Silvestri, S ^a   Vatteroni, E ^a   Dell'Osso, M Catena ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

ADHD; Alzheimer's disease; Anxiety disorders; ATP; Autism; Genetics; Mitochondria; Mitochondrial diseases; Mood disorders; Schizophrenia

Indexed keywords

CELL NUCLEUS DNA; CREATINE PHOSPHATE; CYTOCHROME C OXIDASE; FLAVINE ADENINE NUCLEOTIDE; MITOCHONDRIAL DNA; NEUROLEPTIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ALZHEIMER DISEASE; ANXIETY; APOPTOSIS; ATTENTION DEFICIT DISORDER; AUTISM; AUTOSOMAL RECESSIVE DISORDER; BECK ANXIETY INVENTORY; BEHAVIOR DISORDER; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CARDIOMYOPATHY; CAUDATE NUCLEUS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; ENERGY METABOLISM; GENE MUTATION; HEART CONDUCTION; HUMAN; IMPULSIVENESS; KEARNS SAYRE SYNDROME; LEARNING DISORDER; LEBER HEREDITARY OPTIC NEUROPATHY; LYMPHOCYTE; MAJOR DEPRESSION; MELAS SYNDROME; MERRF SYNDROME; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MITOCHONDRIAL GENE; MITOCHONDRION; MOOD DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALITY DISORDER; PSYCHOSIS; RECEPTOR DOWN REGULATION; RESPIRATORY CHAIN; REVIEW; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTROSCOPY; THOUGHT DISORDER;

EID: 80053526187     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797379221     Document Type: Review

References (117)

1. Altmann, R. Die Elementarorganismen und ihre Beziehungen zu den Zellen.Veit, Leipzig 1890.
2. Benda, C. Ueber die Spermatogenese der Vertebraten und höhererEvertebraten, II. Theil: Die Histiogenese der Spermien. Arch Anat Physiol1898, 73, 393-398.
3. Warburg, O. Über sauerstoffatmende Körnchen aus Leberzellen und überSauerstoffatmung in Berkefeld-Filtraten wässriger Leberextrakte. PflügersArch Gesamte Physiol Menschen Tiere 1913, 154, 599-617.
4. Kalckar, H. Phosphorylation in kidney tissue. Enzymologia, 1937, 2, 47-52.
5. Kennedy, EP, ; Lehninger, AL. Oxidation of fatty acids and tricarboxylic acidcycle intermediates by isolated rat liver mitochondria. J Biol Chem., 1949, 179, 957-72.
6. Palade, GE. The fine structure of mitochondria. Anat Rec., 1952, 114, 427-51.
7. Friedrich, T.; Bottcher, B. The gross structure of the respiratory Complex I:a Lego system. Biochim. Biophys. Acta., 2004, 1608, 1-9. (Pubitemid 38115114)
8. Yankovskaya, V.;Horsefield, R.; Törnroth, S.; Luna-Chavez, C.; Miyoshi, H.; Léger, C.; Byrne, B.; Cecchini, G.; Iwata, S. Architecture of succinatedehydrogenaseand reactive oxygen species generation. Science, 2003, 299, 700-704. (Pubitemid 36159483)
9. Horsefield, R.;Iwata, S.; Byrne, B. Complex II from a structural perspective.Curr Protein Pept Sci., 2004, 5(2), 107-118. (Pubitemid 38380057)
10. Berry, E.A.; Guergova-Kuras, M.; Huang, L.S.; Crofts, A.R. Structure andfunction of cytochrome bc complexes. Annu Rev Biochem., 2000, 69, 1005-75.
11. Michel, H.; Behr, J.; Harrenga, A.; Kannt, A. Cytochrome c oxidase:structure and spectroscopy. Annu Rev Biophys Biomol Struct., 1998, 27, 329-356.
12. Stock, D.; Gibbons, C.; Arechaga, I.; Leslie, A.G.; Walker, J.E. Rotarymechanism of ATP synthase. Curr Opin Struct Biol., 2000, 10(6), 672-679.
13. Alberts, B.;Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P.Molecular Biology of the Cell. Garland Publishing Inc: New York, 1994.
14. Voet, D.; Voet, J.G.; Pratt C.W. Fundamentals of Biochemistry, 2nd ed.;Wiley and Sons: New York, 2006.
15. Henze, K.; Martin, W. (2003). Evolutionary biology: essence ofmitochondria. Nature, 2003, 426 (6963), 127-128.
16. McBride, H.M, ; Neuspiel, M.; Wasiak, S. (2006). Mitochondria: more thanjust a powerhouse. Curr. Biol., 2006, 16 (14), R551.
17. 2+ uptake in apoptosis. CellCalcium, 2006, 40 (5-6), 553-560 (Pubitemid 44660721)
18. Green, DR. Apoptotic pathways: the roads to ruin. Cell., 1998, 94 (6), 695-698.
19. Rossier, M.F. T channels and steroid biosynthesis: in search of a link withmitochondria. Cell Calcium, 2006, 40 (2), 155-164. (Pubitemid 43942298)
20. Chinnery, P.F.; Turnbull, D.M. Mitochondrial medicine. Q J Med., 1997, 90, 657-667. (Pubitemid 27483426)
21. Chinnery, P.F.; Elliot, C.; Green, G.R.; Rees, A.; Coulthard, A.; Turnbull, D.M.;Griffiths, T.D. The spectrum of hearing loss due to mitochondrial DNAdefects. Brain, 2000, 123, 82-92. (Pubitemid 30037971)
22. Schwartz, M.; Vissing, J. New patterns of inheritance in mitochondrialdisease. Biochem Biophys Res Commun., 2003, 310, 247-51.
23. Chinnery, P.F.; Schon E.A. Mitochondria. J Neurol Neurosurg Psychiatry, 2003, 74, 1188-1199.
24. Di Mauro, S.; Schon, E.A. Mitochondrial DNA and diseases of the nervoussystem: the spectrum. Neuroscientist, 1998, 4, 53-63. (Pubitemid 28303606)
25. Boles, R.G.; Burnett, B.B.; Gleditsch, K.; Wong, S.; Guedalia, A.;Kaariainen, A.; Eloed, J.; Stern, A.; Brumm, V. A high predisposition todepression and anxiety in mothers and other matrilineal relatives of childrenwith presumed maternally inherited mitochondrial disorders. Am J MedGenet B Neuropsychiatr Genet., 2005, 137, 20-24. (Pubitemid 41076607)
26. Wallace, D.C.; Singh, G.; Lott, M.T.; Hodge, J.A.; Schurr, T.G.; Lezza, A.M.; Elsas, L.J.; Nikoskelainen, E.K. Mitochondrial DNA mutationassociated with Leber's hereditary optic neuropathy. Science, 1988, 242, 1427-1430. (Pubitemid 19008070)
27. Holt, I.J.; Harding, A.E.; Morgan-Hughes, JA. Delections of musclemitochondrial DNA in patients with mitochondrial myopathies. Nature, 1988, 331, 717-719. (Pubitemid 18062238)
28. Zeviani, M.; Moraes, C.T.; DiMauro, S.; Nakase, H.; Bonilla, E.; Schon, E.A.; Rowland, LP. Deletions of mitochondrial DNA in Kearns-Sayresyndrome. Neurology, 1988, 38, 1339-1346.
29. Ozawa, T. Genetic and functional changes in mitochondria associated withaging. Physiol Rev., 1997, 77, 425-464. (Pubitemid 27184345)
30. Blakely, E.L.; He, L.; Taylor, R.W.; Chinnery, P.F., Lightowlers, R.N.;Schaefer, A.M.: Turnbull, D.M. Mitochondrial DNA deletion in "identical"twin brothers. J Med Genet., 2004, 41, 19.
31. Van Goethem, G.; Martin, J.J.; Van Broeckhoven, C. Progressive externalophthalmoplegia characterized by multiple delections of mitochondrialDNA: unraveling the pathogenesis of human mitochondrial DNA instabilityand the initiation of a genetic classification. Neuromolecular Med., 2003, 3, 129-46. (Pubitemid 37070574)
32. Hirano, M.; Nishigaki, Y.; Marti, R. Mitochondrial neurogastrointestinalencephalomyophathy (MNGIE): a disease of two genomes. Neurologist, 2004, 10, 8-17. (Pubitemid 38140835)
33. Shah, N.S.; Mitchell, W.G.; Boles, R.G. Mitochondrial disorders: apotentially under-recognized etiology of infatile spasms. J Child Neurol, 2002, 17, 369-372. (Pubitemid 34919127)
34. Fadic, R.; Johns, D.R. Clinical spectrum of mitochondrial deseases. SeminNeurol., 1996, 16, 11-20.
35. Varvogli, L.; Waisbren, SE. Personality profiles of mothers of children withmitochondrial disorders. J Inherit Metab Dis., 1999, 22, 615-622. (Pubitemid 29278274)
36. Iwamoto, K.; Bundo, M.; Kato, T. Altered expression of mitochondriarelatedgenes in postmortem brains of patients with bipolar disorder orschizophrenia, as revealed by large-scale DNA microarrayanalysis. Hum MolGenet, 2005, 14, 241-253.
37. Marchbanks, R.M.; Mulcrone, J.; Whatley, S.A. Aspects of oxidativemetabolism in schizophrenia. Br J Psychiatry, 1995, 167, 293-298.
38. Cavelier, L.; Jazin, E.E.; Eriksson, I.; Prince, J.; Bave, U.; Oreland, L.;Gyllensten, U. Decreased cytochrome-c oxidase activity and lack of agerelatedaccumulation of mitochondrial DNA deletions in the brains ofschizophrenics. Genomics, 1995, 29, 217-224.
39. Lindholm, E.; Cavelier, L.; Howell, W.M.; Eriksson, I.; Jalonen, P.;Adolfsson, R.; Blackwood, D.H.; Muir, W.J.; Brookes, A.J.; Gyllensten, U.;Jazin, E.E. Mitochondrial sequence variants in patients with schizophrenia.Eur J Hum Genet., 1997, 5, 406-412. (Pubitemid 28025099)
40. Ben-Shachar, D.; Zuk, R.; Cazawi, H.; Reshef, A.; Sheinkman, A.; Klein, E.lncreased mitochondrial complex I activity in platelets of schizophrenicpatients. Int J Neuropsychopharmacol., 1999, 2, 245-253.
41. Prince, J.A.; Harro, J.; Blennow, K.; Gottfries, C.G.; Oreland, L. Putamenmitochondrial energy metabolism is highly correlated to emotional andintellectual impairment in schizophrenics. Neuropsychopharmacol., 2000, 22, 284-292. (Pubitemid 30089539)
42. Dror, N.; Klein, E.; Karry, R.; Sheinkman, A.; Kirsh, Z.; Mazor, M.;Tzukerman, M.; Ben-Shachar, D.. State-dependent alterations inmitochondrial complex I activity in platelets: a potential peripheral markerfor schizophrenia. Mol Psychiatry, 2002, 7, 995-1001. (Pubitemid 35333055)
43. Karry, R.; Klein, E.; Ben Shachar D. Mitochondrial complex I subunitsexpression is altered in schizophrenia: a postmortem study. Biol Psychiatry, 2004, 55, 676-684. (Pubitemid 38376178)
44. Konradi, C.; Eaton, M.; MacDonald, ML.; Walsh, J.; Benes, FM.; Heckers, S. Molecular evidence for mitochondrial dysfunction in bipolar disorder.Arch Gen Psychiatry, 2004, 61, 300-308. (Pubitemid 38295832)
45. Iwamoto, K.; Bundo, M.; Kato, T. Altered expression of mitochondriarelatedgenes in postmortem brains of patients with bipolar disorder orschizophrenia, as revealed by large-scale DNA microarrayanalysis. Hum MolGenet., 2005, 14, 241-253.
46. Ben-Shachar, D.; Zuk, R.; Gazawi, H.; Ljubuncic, P. Dopamine toxicityinvolves mitochondrial complex I inhibition: implications to dopaminerelatedneuropsychiatric disorders. Biochem Pharmacol., 2004, 67, 1965-1974. (Pubitemid 38591384)
47. Pantelis, C.; Yücel, M.; Wood, S.J.; Velakoulis, D.; Sun, D.; Berger, G.;Stuart, G.W.; Yung, A.; Phillips, L.; McGorry, P.D. Structural brain imagingevidence for multiple pathological processes at different stages of braindevelopment in schizophrenia. Schiz Bull., 2005, 31(3), 672-696. (Pubitemid 41253318)
48. Castellani, R.; Hirai, K.; Aliev, G.; Drew, K.L.; Nunomura, A.; Takeda, A.;Cash, A.D.; Obrenovich, M.E.; Perry, G.; Smith, M.A. Role of mitochondrialdysfunction in Alzheimer's disease. J Neurosci Res., 2002, 70(3), 357-360.
49. Sullivan, P.G.; Brown, MR. Mitochondrial aging and dysfunction inAlzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29(3), 407-410. (Pubitemid 40417592)
50. Chang, T.S. ; Johns, D.R. ; Walker, D. ; De La Cruz, Z. ; Maumence, I.H. ;Green, W.R. Ocular clinicopathologic study of the mitochondrialencephalomyopathy overlap syndrome. Arch Ophthalmol., 1993, 111, 1254-1262. (Pubitemid 23268788)
51. Inagaki, T.; Ishino, H.; Seno, H.; Ohguni, S.; Tanaka, J.; Kato, Y. Psychiatricsymptoms in a patient with diabetes mellitus associated with point mutationin mitochondrial DNA. Biol Psychiatry, 1997, 42, 1067-1069. (Pubitemid 27496437)
52. Suzuki, Y.; Taniyama, M.; Muramatsu, T.; Atsumi, Y.; Hosokawa, K.;Asahina, T.; Shimada, A.; Murata, C.; Matsuoka, K. Diabetes mellitusassociated with 3243 mitochondrial tRNA(Leu(UUR)) mutation: clinicalfeatures and coenzyme Q10 treatment. Mol Aspects Med., 1997, 18, 181-188.
53. Oexle, K.; Zwirner, A. Advanced telomere shortening in respiratory chaindisorders. Hum Mol Genet., 1997, 6, 905-908. (Pubitemid 27239075)
54. Thomeer, E.C.; Verhoeven, W.M.; van de Vlasakker, C.J.; Klompenhouwer, J.L. Psychiatric symptoms in MELAS; a case report. J Neurol NeurosurgPsychiatry, 1998, 64, 692-693.
55. Prayson, R.A.; Wang, N. Mitochondrial myopathy, encephalopathy, lacticacidosis, and strokelike episodes (MELAS) syndrome: an autopsy report.Arch Pathol Lab Med., 1998, 122, 978-981. (Pubitemid 28521044)
56. Shinkai, T.; Nakashima, M.; Ohmori, O.; Terao, T.; Nakamura, J.;Hiramatsu, N.; Hashiguchi, H.; Tsuji, S. Coenzyme Q10 improvespsychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report. AustN Z J Psychiatry, 2000, 34:1034-1035.
57. Spellberg, B.; Carroll, R.M.; Robinson, E.; Brass, E. mtDNA diseases in theprimary care setting. Arch Intern Med., 2001, 161, 2497-2500. (Pubitemid 33043124)
58. Amemiya, S.; Hamamoto, M.; Goto, Y.; Komaki, H.; Nishino, I.; Nonaka, I.;Katayama, Y. Psychosis and progressing dementia: presenting features of amitochondriopathy. Neurology, 2000, 55, 600-601. (Pubitemid 30647271)
59. Hart, Z.H.; Chang, C.H.; Perrin, E.V.; Neerunjun, J.S.; Ayyar, R. Familialpoliodystrophy, mitochondrial myopathy, and lactate academia. ArchNeurol., 1977, 34, 180-185. (Pubitemid 8049782)
60. Kiejna, A.; Di Mauro, S.; Adamowski, T.; Rymaszewska, J.; Leszek, J.;Pachalska, M. Psychiatric symtoms in a patient with the clinical features ofMELAS. Med Sci Monit., 2002, 8, 66-72.
61. Berio, A.; Piazzi, A. A case of Kearns-Sayre syndrome with autoimmunethyroiditis and possible Hashimoto encephalopathy. Panminerva Med., 2002, 44, 265-269. (Pubitemid 41315640)
62. Suomalainen, A.; Majander, A.; Wallin, M.; Setälä, K.; Kontula, K.;Leinonen, H.; Salmi, T.; Paetau, A.; Haltia, M.; Valanne, L.; Lonnqvist, J.;Peltonen, L.; Somer, H. Autosomal dominant progressive externalophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology, 1997, 48, 1244-1253. (Pubitemid 27240542)
63. Siciliano, G.; Tessa, A.; Petrini, S.; Mancuso, M.; Bruno, C.; Grieco, G.S.;Malandrini, A.; DeFlorio, L.; Martini, B.; Federico, A.; Nappi, G.; Santarelli, F.M.; Murri, L. Autosomal dominant external ophthalmoplegia and bipolaraffective disorder associated with a mutation in the ANT1 gene.Neuromuscul Dis., 2003, 13, 162-165. (Pubitemid 36140012)
64. Shanske, A.L.; Shanske, S.; Silvestri, G.; Tanji, K.; Wertheim, D.; Lipper, S.MELAS point mutation with unusual clinical presentation. NeuromusculDis., 1993, 3, 191-193. (Pubitemid 23250402)
65. Onishi, H.; Kawanishi, C.; Iwasawa, T.; Osaka, H.; Hanihara, T.; Inoue, K.;Yamada, Y.; Kosaka, K. Depressive disorder due to mitochondrial transferRNALeu(UUR) mutation. Biol Psychiatry, 1997, 141, 1137-1139. (Pubitemid 27240008)
66. Miyaoka, H.; Suzuki, Y.; Taniyama, M.; Miyaoka, Y.; Shishikura, K.;Kamijima, K.; Atsumi, Y.; Matsuoka, K. Mental disorders in diabeticpatients with mitochondrial transfer RNA(Leu) (UUR) mutation at position3243. Biol Psychiatry, 1997, 42, 524-526. (Pubitemid 27394622)
67. Newman-Toker, D.E.; Horton, J.C.; Lessell, S. Recurrent visual loss in Leberhereditary optic neuropathy. Arch Ophthalmol., 2003, 121, 288-291. (Pubitemid 36184053)
68. Sweeney, M.G.; Bundey, S.; Brockington, M.; Poulton, K.R.; Winer, J.B.;Harding, A.E. Mitochondrial myopathy associated with sudden death inyoung adults and a novel mutation in the mitochondrial DNA leucine transferRNA(UUR) gene. Q J Med., 1993, 86, 709-713.
69. Santorelli, F.M.; Tanji, K.; Sano, M.; Shanske, S.; El-Shahawi, M.; Kranz-Eble, P.; DiMauro, S.; De Vivo, DC. Maternally inherited encephalopathyassociated with a single-base insertion in the mitochondrial tRNATrp gene.Ann Neurol., 1997, 42, 256-260. (Pubitemid 27340474)
70. Jaksch, M.; Lochmuller, H.; Schmitt, F.; Volpel, B.; Obermaier-Kusser, B.;Horvath, R. A mutation in mt tRNALeu(UUR) causing a neuropsychiatricsyndrome with depression and cataract. Neurology, 2001, 57, 1930-1931. (Pubitemid 33096717)
71. Campos, Y.; García, A.M.; Eiris, J.; Fuster, M.; Rubio, J.C.; Martín, M.A.;del Hoyo, P.; Pintos, E.; Castro-Gago, M.; Arenas, J. Mitochondrialmyopathy, cardiomyopathy and psychiatric illness in a Spanish familyharbouring the mtDNA 3303C > T mutation. J Inherit Metab Dis., 2001, 24, 685-687. (Pubitemid 33130091)
72. Houshmand, M.; Gardner, A.; Hällström, T.; Müntzing, K.; Oldfors, A.;Holme, E. Different tissue distribution of a mitochondrial DNA duplicationand the corresponding deletion in a patient with a mild mitochondrialencephalomyopathy: deletion in muscle, duplication in blood. NeuromusculDisord., 2004, 14, 195-201. (Pubitemid 38229888)
73. Burnett, B.B. ; Gardner, A. ; Boles, R.G. Mitochondrial inheritance indepression, dysmotility and migraine? J Affect Dis., 2005, 88, 109-116. (Pubitemid 41160422)
74. Suomalainen, A.; Majander, A.; Haltia, M.; Somer, H.; Lönnqvist, J.;Savontaus, M.L.; Peltonen, L. Multiple deletions of mitochondrial DNA inseveral tissues of a patient with severe retarded depression and familialprogressive external ophthalmoplegia. J Clin Invest., 1992, 90, 61-66.
75. Stewart, J.B.; Naylor, G.J. Manic-depressive psychosis in a patient withmitochondrial myopathy. A case report. Med Sci Res., 1990, 18, 265-266. (Pubitemid 20157040)
76. Ihara, Y.; Namba, R.; Kuroda, S.; Sato, T.; Shirabe, T. Mitochondrialencephalomyopathy (MELAS): pathological study and successful therapywith coenzyme Q10 and idebenone. Neurol Sci., 1989, 90, 263-271. (Pubitemid 19122917)
77. Gardner, A.; Pagani, M.; Wibom, R.; Nennesmo, I.; Jacobsson, H.;Hällström, T. Alterations of rCBF and mitochondrial dysfunction in majordepressive disorder: a case report. Acta Psychiatr Scand., 2003, 107, 233-239.
78. Mendlewicz, J. Molecular genetic studies in affective illness. In: Papolos DF, Lachman HM. Genetic studies in affective disorders. New York: John Wiley & Sons 1994.
79. Baron, M. Novel strategies in molecular genetics of mental illness. BiolPsychiatry, 1994, 35, 757-760. (Pubitemid 24164995)
80. Wallace DC. Mitochondrial diseases in man and mouse. Science, 1999, 283, 1482-1488.
81. Kato, T.; Kato, N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord., 2000, 2, 180-190.
82. Kato, T.; Takahashi, S.; Shioiri, T.; Inubushi, T. Alterations in brainphosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Limagnetic resonance spectroscopy. J Affect Disord., 1993, 27, 53-59. (Pubitemid 23029240)
83. Deicken, R.F.; Weiner, M.W., Fein, G. Decreased temporal lobephosphomonoesters in bipolar disorder. J Affect Disord., 1995, 33, 195-199.
84. Kato, T.; Inubushi, T.; Kato, N. Magnetic resonance spectroscopy inaffective disorders. J Neuropsychiatry Clin Neurosci., 1998, 10, 133-147. (Pubitemid 28241361)
85. Kato, T.; Shioiri, T.; Murashita, J.; Hamakawa, H.; Takahashi, Y.; Inubushi, T.; Takahashi, S. Lateralized abnormality of high energy phosphatemetabolism in the frontal lobes of patients with bipolar disorder detected byphase-encoded 31P-MRS. Psychol Med., 1995, 25, 557-566.
86. Kato, T.; Takahashi, S.; Shioiri, T.; Murashita, J.; Hamakawa, H.; Inubushi, T. Reduction of brain phosphocreatine in bipolar II disorder detected byphosphorus-31 magnetic resonance spectroscopy. J Affect Disord., 1994, 31, 125-133. (Pubitemid 24183900)
87. Eleff, S.M.; Barker, P.B.; Blackband, S.J.; Chatham, J.C.; Lutz, N.W.; Johns, D.R.; Bryan, R.N.; Hurko, O. Phosphorus magnetic resonance spectroscopyof patients with mitochondrial cytopathies demonstrates decreased levels ofbrain phosphocreatine. Ann Neurol., 1990, 27, 626-630. (Pubitemid 20177410)
88. Barbiroli, B.; Montagna, P.; Martinelli, P.; Lodi, R.; Iotti, S.; Cortelli, P.;Funicello, R.; Zaniol, P. Defective brain energy metabolism shown by in vivo31P MR spectroscopy in 28 patients with mitochondrial cytopathies. J CerebBlood Flow Metab., 1993, 13, 469-474. (Pubitemid 23129400)
89. Andreazza, A.C.; Shao, L.; Wang, J.F.; Young, L.T. Mitochondrial complexI activity and oxidative damage to mitochondrial proteins in the prefrontalcortex of patients with bipolar disorder.Arch Gen Psychiatry, 2010, 67(4), 360-368.
90. Kato, T.; Takahashi, Y. Deletion of leukocyte mitochondrial DNA in bipolardisorder. J Affect Disord., 1996, 37, 67-73. (Pubitemid 26126289)
91. kandel, E.R.; Schwartz, J.H.; Jessell, T.M. Principles of neural sciences 4Thedn. McGraw-Hill: New York, NY 2000.
92. Torok, T.L. Neurochemical transmission and sodium-pump. Prog Neurobiol., 1989, 32, 11-76.
93. 2+-dependent regulator protein. J BiolChem., 1977, 252(12), 4108-4117. (Pubitemid 8114432)
94. Culmsee, C.;Mattson, M.P. p53 in neuronal apoptosis. Biochem Biophys Res Commun., 2005, 331(3), 761-777.
95. Miyaoka, H.; Suzuki, Y.; Taniyama, M.; Miyaoka, Y.; Shishikura, K.;Kamijima, K.; Atsumi, Y.; Matsuoka, K. Mental disorders in diabeticpatients with mitochondrial transfer RNA(Leu) (UUR) mutation at position3243. Biol Psychiatry, 1997, 42, 524-526. (Pubitemid 27394622)
96. Graf, W.D.; Marin-Garcia, J.; Gao, H.G.; Pizzo, S.; Naviaux, R.K.;Markusic, D.; Barshop, B.A.; Courchesne, E.; Haas, R.H. Autism associatedwith the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J ChildNeurol., 2000, 15, 357-361. (Pubitemid 30418050)
97. Shoffner, J.M.; Bialer, M.G.; Pavlakis, S.G.; Lott, M.; Kaufman, A.; Dixon, J.; Teichberg, S.; Wallace, D.C. Mitochondrial encephalomyopathyassociated with a single nucleotide pair deletion in the mitochondrialtRNALeu(UUR) gene. Neurology, 1995, 45, 286-292.
98. Wallace, D.C.; Lott, M.T.; Shoffner, J.M.; Ballinger, S. Mitochondrial DNAmutations in epilepsy and neurological disease. Epilepsia, 1994, 35, 43-50.
99. Giulivi, C.; Zhang, Y.F.; Omanska-Klusek, A.; Ross-Inta, C.; Wong, S.;Hertz-Picciotto, I.;Tassone, F.; Pessah, I.N. Mitochondrial dysfunction inautism. JAMA, 2010, 304(21), 2389-2396.
100. Robert, L.; Nussbaum, M.D.; Ellis, C.E. Alzheimer's disease and Parkinson'sdisease. N Engl J Med., 2003, 348(14), 1356-1364.
101. Cutter, W.J.; Norbury, R.; Murphy, D.G. Oestrogen, brain function, andneuropsychiatric disorders. J Neurol Neurosurg Psychiatry, 2003, 74(7), 837-840.
102. Sherwin, B.B. Estrogen and cognitive functioning in women. Endocr Rev., 2003, 24(2), 133-151. (Pubitemid 36515282)
103. Lambert, J.C.; Coyle, N.; Lendon C. The allelic modulation of apolipoproteinE expression by oestrogen: potential relevance for Alzheimer's disease. JMed Genet., 2004, 41, 104-112. (Pubitemid 38221748)
104. Praticò D. Peripheral biomarkers of oxidative damage in Alzheimer'sdisease: the road ahead. Neurobiol Aging, 2005, 26(5), 581-583. (Pubitemid 40228748)
105. Cortopassi, G.; Wang E. Modelling the effects of age-related mtDNAmutation accumulation; complex I deficiency, superoxide and cell death.Biochim Biophys Acta., 1995, 1271(1), 171-176.
106. Wei, Y.A.; Kao, S.H., Lee, H.C. Simultaneous increase of mitochondrialDNA deletions and lipid peroxidation in human aging. Annals New YorkAcad. Sci., 1996, 786, 24-43.
107. Wallace, D.C.; Lott, M.T.; Brown, M.D. Mitochondrial defects inneurodegenerative diseases and aging in : M.F. Beal, N. Howell Eds, Mitochondria and Free radicals In Neurodegenerative diseases. Wiley-Liss, New York, 1997, pp. 283-307.
108. Melov, S.; Schneider, J.A.; Coskun, P.E.; Bennett, D.A.; Wallace D.C.Mitochondrial DNA rearrangements in aging human brain and in situ PCR ofmtDNA. Neurobiol Aging., 1999, 20(5), 565-571. (Pubitemid 30001470)
109. Michikawa, Y.; Mazzucchelli, F.; Bresolin, N.; Scarlato, G.; Attardi, G.Aging-dependent large accumulation of point mutations in the humanmtDNA control region for replication. Science, 1999, 286(5440), 774-779.
110. Lin, M.T.; Simon D.K., Ahn, C.H.; Kin L.M.; Beal M.F. High aggregateburden of somatic mtDNA point mutations in aging and Alzheimer's diseasebrain. Hum Mol Genet., 2002, 11(2), 133-145. (Pubitemid 34157005)
111. Corral-Debrinski, M.; Horton, T.; Lott, MT.; Shoffner, JM.; McKee, AC.;Beal, MF.; Graham, B.H., Wallace, D.C. Marked changes inmitochondrial DNA deletion levels in Alzheimer brains. Genomics, 1994, 23(2), 471-476. (Pubitemid 24308270)
112. Beal, M.F. Oxidative damage as an early marker of Alzheimer's disease andmild cognitive impairment. Neurobiol Aging., 2005, 26(5), 585-586. (Pubitemid 40228749)
113. Small, G.W. ; Mazziotta, J.C. ; Collins, M.T. ; Baxter, L.R. ; Phelps, M.E. ;Mandelkern, M.A. ; Kaplan, A. ; La Rue, A. ; Adamson, C.F. ; Chang, L.Apolipoprotein E type 4 allele and cerebral glucose metabolism in relativesat risk for familial Alzheimer disease. JAMA, 1995, 273(12), 942-947.
114. Brown, W.M. Polymorphism in mitochondrial DNA of humans as revealedby restriction endonuclease analysis. Proc Natl Acad Sci U S A. 1980, 77(6), 3605-3609.
115. Manczak, M.; Anekonda, T.S.; Henson, E.; Park, B.S.; Quinn, J.; Reddy, P.H. Mitochondria are a direct site of A beta accumulation in Alzheimer'sdisease neurons:implications for free radical generation and oxidativedamage in disease progression. Hum Mol Genet., 2006, 15(9), 1437-49.
116. Lin, M.T.; Simon, D.K.; Ahn, C.H.; Kin, L.M.; Beal, M.F. High aggregateburden of somatic mtDNA point mutations in aging and Alzheimer's diseasebrain. Hum Mol Genet., 2002, 11(2), 133-145. (Pubitemid 34157005)
117. Wang, X.; Su, B.; Siedlak, S.L.; Moreira, P.I.; Fujioka, H.; Wang, Y.;Casadesus, G.; Zhu, X. Amyloid-beta overproduction causes abnormalmitochondrial dynamics via differential modulation of mitochondrialfission/fusion proteins. Proc Natl Acad Sci U S A, 2008, 105(49), 19318-19323.